WallStreetZenWallStreetZen

NASDAQ: NYXH
Nyxoah Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NYXH

Based on 1 analyst offering 12 month price targets for Nyxoah Sa

Min Forecast
$9.00+80%
Avg Forecast
$9.00+80%
Max Forecast
$9.00+80%

Should I buy or sell NYXH stock?

Based on 1 analyst offering ratings for Nyxoah Sa.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NYXH's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NYXH as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their NYXH stock forecasts and price targets.

NYXH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-14

1 of 1

Forecast return on equity

Is NYXH forecast to generate an efficient return?

Company
N/A
Industry
23.01%
Market
232.29%

Forecast return on assets

Is NYXH forecast to generate an efficient return on assets?

Company
N/A
Industry
17.15%

NYXH earnings per share forecast

What is NYXH's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$2.25
Avg 2 year Forecast
-$2.12
Avg 3 year Forecast
-$1.61

NYXH revenue forecast

What is NYXH's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$8.4M+26.5%
Avg 2 year Forecast
$35.3M+431.4%
Avg 3 year Forecast
$74.9M+1,028.42%
NYXH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NYXH revenue growth forecast

How is NYXH forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
122.85%
Industry
8.2%
Market
25.7%
NYXH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NYXH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NYXH vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
NYXH$5.00$9.00+80.00%Strong Buy
SMTI$21.54$36.00+67.13%Buy
INFU$9.51$14.50+52.47%Strong Buy
UTMD$55.38N/AN/A
KRMD$4.32N/AN/A
View Top Medical Stocks

Nyxoah Sa Stock Forecast FAQ

Is Nyxoah Sa Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NYXH) stock is to Strong Buy NYXH stock.

Out of 1 analyst, 1 (100%) are recommending NYXH as a Strong Buy, 0 (0%) are recommending NYXH as a Buy, 0 (0%) are recommending NYXH as a Hold, 0 (0%) are recommending NYXH as a Sell, and 0 (0%) are recommending NYXH as a Strong Sell.

If you're new to stock investing, here's how to buy Nyxoah Sa stock.

What is NYXH's earnings growth forecast for 2025-2027?

(NASDAQ: NYXH) Nyxoah Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 27.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 43.33%.

Nyxoah Sa's earnings in 2025 is -$97,348,837.On average, 11 Wall Street analysts forecast NYXH's earnings for 2025 to be -$84,460,742, with the lowest NYXH earnings forecast at -$94,192,349, and the highest NYXH earnings forecast at -$72,142,299. On average, 11 Wall Street analysts forecast NYXH's earnings for 2026 to be -$79,444,759, with the lowest NYXH earnings forecast at -$117,372,497, and the highest NYXH earnings forecast at -$54,432,425.

In 2027, NYXH is forecast to generate -$60,413,309 in earnings, with the lowest earnings forecast at -$85,361,816 and the highest earnings forecast at -$35,498,591.

What is NYXH's revenue growth forecast for 2025-2027?

(NASDAQ: NYXH) Nyxoah Sa's forecast annual revenue growth rate of 122.85% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.2%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.7%.

Nyxoah Sa's revenue in 2025 is $6,556,976.On average, 11 Wall Street analysts forecast NYXH's revenue for 2025 to be $315,075,811, with the lowest NYXH revenue forecast at $226,920,662, and the highest NYXH revenue forecast at $406,046,817. On average, 11 Wall Street analysts forecast NYXH's revenue for 2026 to be $1,323,603,745, with the lowest NYXH revenue forecast at $803,608,514, and the highest NYXH revenue forecast at $1,899,878,604.

In 2027, NYXH is forecast to generate $2,810,639,925 in revenue, with the lowest revenue forecast at $2,281,220,954 and the highest revenue forecast at $3,211,918,555.

What is NYXH's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: NYXH) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 17.15%.

What is NYXH's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NYXH price target, the average NYXH price target is $9.00, with the highest NYXH stock price forecast at $9.00 and the lowest NYXH stock price forecast at $9.00.

The Wall Street analyst predicted that Nyxoah Sa's share price could reach $9.00 by Nov 14, 2026. The average Nyxoah Sa stock price prediction forecasts a potential upside of 80% from the current NYXH share price of $5.00.

What is NYXH's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: NYXH) Nyxoah Sa's current Earnings Per Share (EPS) is -$2.61. On average, analysts forecast that NYXH's EPS will be -$2.25 for 2025, with the lowest EPS forecast at -$2.51, and the highest EPS forecast at -$1.92. On average, analysts forecast that NYXH's EPS will be -$2.12 for 2026, with the lowest EPS forecast at -$3.13, and the highest EPS forecast at -$1.45. In 2027, NYXH's EPS is forecast to hit -$1.61 (min: -$2.27, max: -$0.95).

What is NYXH's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: NYXH) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.